Stem and progenitor cell alterations in myelodysplastic syndromes

Medicine & Life Sciences

• 3-tyrosine 17%
• Angiopoietin-1 15%
• Cell Count 8%
• Clinical Studies 7%
• Cytogenetics 10%
• Disease Progression 8%
• Epidermal Growth Factor 10%
• Hematopoietic Stem Cells 32%
• Immunoglobulins 9%
• Interleukin-1 Receptor Accessory Protein 20%
• Interleukin-1 Receptor-Associated Kinases 17%
• Interleukin-1 Receptors 13%
• Interleukin-8 10%
• MicroRNAs 9%
• Mutation 6%
• Myelodysplastic Syndromes 100%
• p21-Activated Kinases 15%
• Population 4%
• Protein-Tyrosine Kinases 10%
• Proteins 4%
• Recurrence 12%
• STAT3 Transcription Factor 13%
• Stem Cells 65%
• T-Lymphocytes 6%
• Therapeutics 3%
• Transforming Growth Factors 11%
• Tumor Necrosis Factor Receptor-Associated Peptides and Proteins 16%

Chemical Compounds

• Chemical Transformation 27%
• Cytogenetics 62%
• Marker 38%
• MicroRNA 54%
• Mutation 37%
• Protein 36%
• Tyrosine 40%